Adderall Sales Suspended in Canada
Health Canada has suspended the market authorization of Shire Pharmaceuticals' Adderall XR, saying a recent review of Shire safety data revealed an association between the attention-deficit/hyperactivity disorder drug and heart-related deaths and strokes in both children and adults.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.